a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.
Ticker / NAME | Correlation To NKTX | 1D Price Change % | ||
---|---|---|---|---|
NKTX | 100% | -4.59% | ||
FATE - NKTX | 51% Loosely correlated | -8.82% | ||
PGEN - NKTX | 49% Loosely correlated | -3.57% | ||
ALLO - NKTX | 46% Loosely correlated | -4.23% | ||
BCRX - NKTX | 46% Loosely correlated | -2.30% | ||
CRBU - NKTX | 45% Loosely correlated | -6.18% | ||
More |
Ticker / NAME | Correlation To NKTX | 1D Price Change % |
---|---|---|
NKTX | 100% | -4.59% |
NKTX (1 stocks) | 71% Closely correlated | -7.04% |
biopharmaceutical (10 stocks) | 54% Loosely correlated | -2.76% |
cancer (82 stocks) | 53% Loosely correlated | -2.38% |
treatment (56 stocks) | 38% Loosely correlated | -1.12% |